Kathy Harry

546 total citations
9 papers, 435 citations indexed

About

Kathy Harry is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Kathy Harry has authored 9 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Kathy Harry's work include Drug Transport and Resistance Mechanisms (6 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Kathy Harry is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Kathy Harry collaborates with scholars based in United States, Thailand and Austria. Kathy Harry's co-authors include Carol J. Soroka, James L. Boyer, Albert Mennone, Lee R. Hagey, Masashi Adachi, Shi‐Ying Cai, John D. Schuetz, Jittima Weerachayaphorn, Marc Pypaert and Wei Wang and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Kathy Harry

9 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Harry United States 7 280 144 124 111 101 9 435
Hidde H. Huidekoper Netherlands 15 191 0.7× 214 1.5× 107 0.9× 208 1.9× 59 0.6× 44 651
Chizuru Watanabe Japan 12 126 0.5× 144 1.0× 156 1.3× 196 1.8× 35 0.3× 19 594
R. Lenzen Germany 11 112 0.4× 199 1.4× 109 0.9× 150 1.4× 177 1.8× 22 480
Thomas Kühlkamp Germany 7 334 1.2× 222 1.5× 110 0.9× 95 0.9× 68 0.7× 7 442
Leila Valanejad United States 13 209 0.7× 114 0.8× 151 1.2× 208 1.9× 69 0.7× 15 481
Sawkat M. Anwer United States 9 250 0.9× 126 0.9× 97 0.8× 139 1.3× 83 0.8× 14 428
P. Tietz United States 7 321 1.1× 292 2.0× 71 0.6× 123 1.1× 79 0.8× 10 504
Micheline Dumont France 12 375 1.3× 282 2.0× 166 1.3× 71 0.6× 153 1.5× 21 597
Giancarlo Lunazzi Italy 11 180 0.6× 61 0.4× 50 0.4× 139 1.3× 17 0.2× 11 354
O. C. Ng United States 9 349 1.2× 246 1.7× 87 0.7× 140 1.3× 115 1.1× 10 540

Countries citing papers authored by Kathy Harry

Since Specialization
Citations

This map shows the geographic impact of Kathy Harry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Harry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Harry more than expected).

Fields of papers citing papers by Kathy Harry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Harry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Harry. The network helps show where Kathy Harry may publish in the future.

Co-authorship network of co-authors of Kathy Harry

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Harry. A scholar is included among the top collaborators of Kathy Harry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Harry. Kathy Harry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Li, Man, Carol J. Soroka, Kathy Harry, & James L. Boyer. (2016). CFTR-associated ligand is a negative regulator of Mrp2 expression. American Journal of Physiology-Cell Physiology. 312(1). C40–C46. 2 indexed citations
2.
Weerachayaphorn, Jittima, Yuhuan Luo, Albert Mennone, et al.. (2013). Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice. Journal of Hepatology. 60(1). 160–166. 41 indexed citations
3.
Svejda, Bernhard, Mark Kidd, Andrew T. Timberlake, et al.. (2013). Serotonin and the 5‐HT7 receptor: The link between hepatocytes, IGF‐1 and small intestinal neuroendocrine tumors. Cancer Science. 104(7). 844–855. 34 indexed citations
4.
Weerachayaphorn, Jittima, Albert Mennone, Carol J. Soroka, et al.. (2012). Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 302(9). G925–G936. 49 indexed citations
5.
Mennone, Albert, Carol J. Soroka, Kathy Harry, & James L. Boyer. (2010). Role of Breast Cancer Resistance Protein in the Adaptive Response to Cholestasis. Drug Metabolism and Disposition. 38(10). 1673–1678. 30 indexed citations
6.
Li, Man, Wei Wang, Carol J. Soroka, et al.. (2010). NHERF-1 Binds to Mrp2 and Regulates Hepatic Mrp2 Expression and Function. Journal of Biological Chemistry. 285(25). 19299–19307. 44 indexed citations
7.
Tradtrantip, Lukmanee, Pawinee Piyachaturawat, Carol J. Soroka, et al.. (2007). Phloracetophenone-induced choleresis in rats is mediated through Mrp2. American Journal of Physiology-Gastrointestinal and Liver Physiology. 293(1). G66–G74. 5 indexed citations
8.
Mennone, Albert, Carol J. Soroka, Shi‐Ying Cai, et al.. (2006). Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology. 43(5). 1013–1021. 138 indexed citations
9.
Wang, Wei, Carol J. Soroka, Albert Mennone, et al.. (2006). Radixin Is Required to Maintain Apical Canalicular Membrane Structure and Function in Rat Hepatocytes. Gastroenterology. 131(3). 878–884. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026